An ETP model (exclusion-tolerance-progression) for multi drug resistance

<p>Abstract</p> <p>Background</p> <p>It is known that sensitivity or resistance of tumor cells to a given chemotherapeutic agent is an acquired characteristic(s), depending on the heterogeneity of the tumor mass subjected to the treatment. The clinical success of a chem...

Full description

Bibliographic Details
Main Author: Kannan Subburaj
Format: Article
Language:English
Published: BMC 2005-04-01
Series:Theoretical Biology and Medical Modelling
Subjects:
Online Access:http://www.tbiomed.com/content/2/1/17
id doaj-2ba1a8a9bf1f47fabd188af43219416d
record_format Article
spelling doaj-2ba1a8a9bf1f47fabd188af43219416d2020-11-24T20:53:22ZengBMCTheoretical Biology and Medical Modelling1742-46822005-04-01211710.1186/1742-4682-2-17An ETP model (exclusion-tolerance-progression) for multi drug resistanceKannan Subburaj<p>Abstract</p> <p>Background</p> <p>It is known that sensitivity or resistance of tumor cells to a given chemotherapeutic agent is an acquired characteristic(s), depending on the heterogeneity of the tumor mass subjected to the treatment. The clinical success of a chemotherapeutic regimen depends on the ratio of sensitive to resistant cell populations.</p> <p>Results</p> <p>Based on findings from clinical and experimental studies, a unifying model is proposed to delineate the potential mechanism by which tumor cells progress towards multi drug resistance, resulting in failure of chemotherapy.</p> <p>Conclusion</p> <p>It is suggested that the evolution of multi drug resistance is a developmentally orchestrated event. Identifying stage-specific time windows during this process would help to identify valid therapeutic targets for the effective elimination of malignancy.</p> http://www.tbiomed.com/content/2/1/17ETP ModelDrug resistanceDrug sensitivityPhysiological drug resistancePathological drug resistance
collection DOAJ
language English
format Article
sources DOAJ
author Kannan Subburaj
spellingShingle Kannan Subburaj
An ETP model (exclusion-tolerance-progression) for multi drug resistance
Theoretical Biology and Medical Modelling
ETP Model
Drug resistance
Drug sensitivity
Physiological drug resistance
Pathological drug resistance
author_facet Kannan Subburaj
author_sort Kannan Subburaj
title An ETP model (exclusion-tolerance-progression) for multi drug resistance
title_short An ETP model (exclusion-tolerance-progression) for multi drug resistance
title_full An ETP model (exclusion-tolerance-progression) for multi drug resistance
title_fullStr An ETP model (exclusion-tolerance-progression) for multi drug resistance
title_full_unstemmed An ETP model (exclusion-tolerance-progression) for multi drug resistance
title_sort etp model (exclusion-tolerance-progression) for multi drug resistance
publisher BMC
series Theoretical Biology and Medical Modelling
issn 1742-4682
publishDate 2005-04-01
description <p>Abstract</p> <p>Background</p> <p>It is known that sensitivity or resistance of tumor cells to a given chemotherapeutic agent is an acquired characteristic(s), depending on the heterogeneity of the tumor mass subjected to the treatment. The clinical success of a chemotherapeutic regimen depends on the ratio of sensitive to resistant cell populations.</p> <p>Results</p> <p>Based on findings from clinical and experimental studies, a unifying model is proposed to delineate the potential mechanism by which tumor cells progress towards multi drug resistance, resulting in failure of chemotherapy.</p> <p>Conclusion</p> <p>It is suggested that the evolution of multi drug resistance is a developmentally orchestrated event. Identifying stage-specific time windows during this process would help to identify valid therapeutic targets for the effective elimination of malignancy.</p>
topic ETP Model
Drug resistance
Drug sensitivity
Physiological drug resistance
Pathological drug resistance
url http://www.tbiomed.com/content/2/1/17
work_keys_str_mv AT kannansubburaj anetpmodelexclusiontoleranceprogressionformultidrugresistance
AT kannansubburaj etpmodelexclusiontoleranceprogressionformultidrugresistance
_version_ 1716797305037783040